Talus Bio

talus.bio

Talus Bioscience is a pioneering biotechnology company focused on drug discovery for transcription factors, particularly in the context of challenging diseases like cancer. Their innovative MARMOT platform integrates functional proteomics, automated biology, and machine learning to target previously undruggable transcription factors in their native cellular environments. With a highly interdisciplinary team comprising over 50% PhD scientists and significant academic recognition, Talus Bio is positioned to accelerate drug development for rare and incurable childhood cancers driven by genome regulators. The company aims to unlock the therapeutic potential of transcription factors, which hold immense promise for treating a variety of diseases, including cancer and diabetes.